CN201631907U - Transdermal delivery patch - Google Patents
Transdermal delivery patch Download PDFInfo
- Publication number
- CN201631907U CN201631907U CN2010200102248U CN201020010224U CN201631907U CN 201631907 U CN201631907 U CN 201631907U CN 2010200102248 U CN2010200102248 U CN 2010200102248U CN 201020010224 U CN201020010224 U CN 201020010224U CN 201631907 U CN201631907 U CN 201631907U
- Authority
- CN
- China
- Prior art keywords
- packing ring
- electrode
- electrode contact
- washer
- layer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Abstract
The utility model relates to the field of medical equipment, in particular to a transdermal delivery patch for a treatment head of a target delivery control instrument, which solves the problems of the prior art, such as poor treatment effect and loose contact with the skin. The transdermal delivery patch is provided with an electrode-connecting disk, a washer I, a washer II, a medicine layer and a sticky layer, the washer I is stuck or pressed on the upper surface of the electrode-connecting disk, a mating hole is formed on the inner side of the washer I, the washer II is stuck or pressed on the lower surface of the electrode-connecting disk, and the medicine layer is mounted on the inner side of the washer II. The convex end of a treatment electrode in the treatment head of the target delivery control instrument can be inserted in the mating hole of the transdermal delivery patch, so that the treatment electrode in the treatment head of the target delivery control instrument is connected with the electrode-connecting disk in a contacting manner, consequently, the conductivity is high, and the treatment effect is better. In the transdermal delivery patch, the medicine layer is flushed with the outer end surface of the washer, and thereby can be more tightly contacted with the skin.
Description
Technical field
This utility model relates to field of medical, is specially a kind of percutaneous dosing paster that is used for target position transmission control instrument treatment head.
Background technology
(transdermal delivery systems, the TDS) percutaneous dosing paster of Shi Yonging can enter human circulation by intact skin by controlled release drug to transdermal drug delivery system, the effect of performance Drug therapy.At present, existing paster is formed through sticking or compacting in certain sequence by backing layer, medicine storing layer, absorption pad, pressure sensitive adhesive, overcoat, and backing layer plays the support effect, and medicine storing layer, absorption pad are relied on thereon, is made by impermeable material.Medicine storing layer is made up of medicine and substrate, plays medicine storage, controlled-release function.Absorption pad is used for absorbing the moisture content that use occurs, and pressure-sensitive adhesive is affixed on human body skin, overcoat protection release face and pressure sensitive adhesive.
China's utility application (application number 200920013161.9) provides a kind of treatment head of target position transmission control instrument.As shown in Figure 1, the treatment head of target position transmission control instrument mainly comprises: upper shell 1, lower house 2, ultrasonic transducer wafer 3, insulating barrier (silicone rubber) 4, therapeutic electrode (steel disc) 5, fixed claw 6 etc., upper shell 1 is the female cap structure, lower house 2 is the hollow structure of middle perforate, upper shell 1 docks with lower house 2, middle tapping at described lower house 2 sets gradually bonding ultrasonic transducer wafer 3 mutually, insulating barrier 4 and therapeutic electrode 5, insulating barrier 4, therapeutic electrode 5 protrudes from the outer face of lower house 2, therapeutic electrode 5 is coated on the outer face and the side of insulating barrier 4, and therapeutic electrode 5 is connected in the inner face of lower house 2, upper shell 1 is connected by the draw-in groove 7 of its end face and the projection 8 of lower house 2 inner faces, upper shell 1 end face is pushed down the access section of therapeutic electrode 5 and lower house 2 inner faces, inner surface at upper shell 1 is provided with fixed claw 6, and fixed claw 6 is corresponding with ultrasonic transducer wafer 3.During assembling, fixed claw 6 contacts at ultrasonic transducer wafer 3.
Above-mentioned target position transmission control instrument treatment head in use, if use common paster, exist therapeutic effect relatively poor, with problem such as contact skin defective tightness, so need a kind of and a target position transmission control instrument treatment matching used percutaneous dosing paster.
The utility model content
The purpose of this utility model is to provide a kind of percutaneous dosing paster that is used for target position transmission control instrument treatment head, solve the therapeutic effect that exists in the prior art relatively poor, with problem such as contact skin defective tightness.
The technical solution of the utility model is:
A kind of percutaneous dosing paster, described percutaneous dosing paster are provided with electrode contact, packing ring I, packing ring II, medicine layer and adhered layer, and the upper surface of electrode contact is bonding or be crimped with packing ring I, and packing ring I inboard forms mating holes; The lower surface bonds of electrode contact or be crimped with packing ring II, packing ring II is equipped with medicine layer in the inboard.
Described percutaneous dosing paster, medicine layer is concordant with the outer face of packing ring II.
Described percutaneous dosing paster, bonding or be crimped with adhered layer at the electrode contact lower surface edge.
A kind of percutaneous dosing paster, described percutaneous dosing paster are provided with electrode contact, medicine layer, adhered layer and packing ring III, and the upper surface center indent of electrode contact forms mating holes; The lower surface bonds of electrode contact or be crimped with packing ring III, packing ring III is equipped with medicine layer in the inboard.
Described percutaneous dosing paster, medicine layer is concordant with the outer face of packing ring III.
Described percutaneous dosing paster, bonding or be crimped with adhered layer at the electrode contact lower surface edge.
The beneficial effects of the utility model are:
1, in this utility model percutaneous dosing paster, the upper surface of electrode contact is bonding or be crimped with packing ring, and the packing ring inboard forms mating holes; Perhaps, the upper surface center indent of electrode contact forms mating holes; Described mating holes is used for cooperating with the protruding end plug-in mounting of target position transmission control instrument treatment head therapeutic electrode, therapeutic electrode is contacted with electrode contact be connected, and electric conductivity is strong, and therapeutic effect is better.
2, in this utility model percutaneous dosing paster, the lower surface bonds of electrode contact or be crimped with packing ring, medicine layer is equipped with in the packing ring inboard, and medicine layer is concordant with the outer face of packing ring, thereby makes medicine layer and contact skin tightr.
Description of drawings
Fig. 1 is the structural representation of target position transmission control instrument treatment head.
Fig. 2 (a)-(b) is a structural representation of this utility model percutaneous dosing paster.
Fig. 3 (a)-(b) is another structural representation of this utility model percutaneous dosing paster.
Among the figure, 1 upper shell; 2 lower houses; 3 ultrasonic transducer wafers; 4 insulating barriers; 5 therapeutic electrodes; 6 fixed claws; 7 draw-in grooves; 8 projectioies; 9 electrode contacts; 10 packing ring I; 11 packing ring II; 12 medicine layers; 13 adhered layers; 14 mating holes; 15 packing ring III.
The specific embodiment
Shown in Fig. 2 (a)-(b), a structure of this utility model percutaneous dosing paster mainly comprises: electrode contact 9, packing ring I 10, packing ring II 11, medicine layer 12 and adhered layer 13 etc., the upper surface of electrode contact 9 is bonding or be crimped with packing ring I 10, the packing ring I 10 inboard mating holes 14 that form, described mating holes 14 is used for cooperating with the protruding end plug-in mounting of target position transmission control instrument shown in Figure 1 treatment head therapeutic electrode 5, therapeutic electrode 5 is contacted with electrode contact 9 be connected; The lower surface bonds of electrode contact 9 or be crimped with packing ring II 11, packing ring II is equipped with medicine layer 12 in 11 inboards, and medicine layer 12 is concordant with the outer face of packing ring II 11; Bonding or be crimped with adhered layer 13 at electrode contact 9 lower surface edges, adhered layer 13 is positioned at the outside of packing ring II 11.
Shown in Fig. 3 (a)-(b), another structure of this utility model percutaneous dosing paster mainly comprises: electrode contact 9, medicine layer 12, adhered layer 13 and packing ring III15 etc., the upper surface center indent of electrode contact 9, form mating holes 14, described mating holes 14 is used for cooperating with the protruding end plug-in mounting of target position transmission control instrument shown in Figure 1 treatment head therapeutic electrode 5, therapeutic electrode 5 is contacted with electrode contact 9 be connected; The lower surface bonds of electrode contact 9 or be crimped with packing ring III15, packing ring III15 is equipped with medicine layer 12 in the inboard, and medicine layer 12 is concordant with the outer face of packing ring III15; Bonding or be crimped with adhered layer 13 at electrode contact 9 lower surface edges, adhered layer 13 is positioned at the outside of packing ring III15.
In this utility model, electrode contact 9 adopts aluminium flake, and packing ring I 10, packing ring II 11 and packing ring III15 adopt polyurethane foam, and adhered layer 13 adopts pressure sensitive adhesive.
Claims (6)
1. percutaneous dosing paster, it is characterized in that: described percutaneous dosing paster is provided with electrode contact, packing ring I, packing ring II, medicine layer and adhered layer, and the upper surface of electrode contact is bonding or be crimped with packing ring I, the inboard mating holes that forms of packing ring I; The lower surface bonds of electrode contact or be crimped with packing ring II, packing ring II is equipped with medicine layer in the inboard.
2. according to the described percutaneous dosing paster of claim 1, it is characterized in that: medicine layer is concordant with the outer face of packing ring II.
3. according to the described percutaneous dosing paster of claim 1, it is characterized in that: bonding or be crimped with adhered layer at the electrode contact lower surface edge.
4. percutaneous dosing paster, it is characterized in that: described percutaneous dosing paster is provided with electrode contact, medicine layer, adhered layer and packing ring III, and the upper surface center indent of electrode contact forms mating holes; The lower surface bonds of electrode contact or be crimped with packing ring III, packing ring III is equipped with medicine layer in the inboard.
5. according to the described percutaneous dosing paster of claim 4, it is characterized in that: medicine layer is concordant with the outer face of packing ring III.
6. according to the described percutaneous dosing paster of claim 4, it is characterized in that: bonding or be crimped with adhered layer at the electrode contact lower surface edge.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010200102248U CN201631907U (en) | 2010-01-13 | 2010-01-13 | Transdermal delivery patch |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010200102248U CN201631907U (en) | 2010-01-13 | 2010-01-13 | Transdermal delivery patch |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN201631907U true CN201631907U (en) | 2010-11-17 |
Family
ID=43076381
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010200102248U Expired - Lifetime CN201631907U (en) | 2010-01-13 | 2010-01-13 | Transdermal delivery patch |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN201631907U (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103269748A (en) * | 2010-12-22 | 2013-08-28 | 帝国制药株式会社 | Electrode pad for iontophoresis |
-
2010
- 2010-01-13 CN CN2010200102248U patent/CN201631907U/en not_active Expired - Lifetime
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103269748A (en) * | 2010-12-22 | 2013-08-28 | 帝国制药株式会社 | Electrode pad for iontophoresis |
| CN103269748B (en) * | 2010-12-22 | 2016-02-17 | 帝国制药株式会社 | For the electronic pads of iontophoresis treatment |
| US10342968B2 (en) | 2010-12-22 | 2019-07-09 | Teikoku Seiyaku Co., Ltd. | Electrode pad used for iontophoresis treatment |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2012078857A3 (en) | Electrode with redundant impedance reduction | |
| WO2010093687A3 (en) | Kit, system and method for transdermal iontophoretic delivery of therapeutic agents | |
| WO2008038241A3 (en) | Electrically activated gel array for transdermal drug delivery | |
| CN201631907U (en) | Transdermal delivery patch | |
| WO2011124253A3 (en) | A device comprising a conductive surface and a conductive polymer for adhesion of cells and tissue | |
| CN203506331U (en) | Wall hook | |
| CN201423082Y (en) | Long-acting ion introduction patch convenient for storing and carrying | |
| CN202829923U (en) | Encapsulation adhesive tape for solar cell module | |
| US8160673B2 (en) | Medical electrode | |
| TWI339426B (en) | Gel-joint encapsulated integrated circuit and a substrate structure are provided | |
| CN212756479U (en) | Traditional Chinese medicine patch | |
| CN202516157U (en) | Output device of ultrasonic intermediate frequency drug guiding instrument | |
| CN204951679U (en) | Externally applied drug helps absorbs unleaded subsides agent | |
| CN214050171U (en) | Electrode patch for ultrasonic conductance medicine permeation | |
| CN205073512U (en) | Take supersound conductivity meter of magnetism physiotherapy electrode | |
| CN217593600U (en) | Enhanced ultrasonic coupling electrode patch | |
| CN202605118U (en) | Waterproof bacteria-blocking hydrocolloid dressings | |
| CN203075468U (en) | Hydraulic conductive rubber electrode plate | |
| CN215386998U (en) | Soluble hyaluronic acid beauty microneedle patch | |
| CN205251837U (en) | Film dressing | |
| CN208541355U (en) | Pressing hemostat | |
| CN213963890U (en) | Practical self-heating type ear acupoint plaster | |
| CN216497084U (en) | Electrode patch for ultrasonic physiotherapy | |
| JPS59118167A (en) | Conductor for iontophrese and plaster structure | |
| CN104367142A (en) | Wall hook |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: DU NAN Free format text: FORMER OWNER: XU LINA Effective date: 20121106 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 110005 SHENYANG, LIAONING PROVINCE TO: 110023 SHENYANG, LIAONING PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20121106 Address after: 110023 No. 47-2 Shen Liaodong Road, Tiexi District, Liaoning, Shenyang Patentee after: Du Nan Address before: 110005 a business building 183, five South Road, Heping District, Liaoning, Shenyang, 712 Patentee before: Xu Lina |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20170804 Address after: 110000 Liaoning Province, Shenyang City District Hunhe Street No. 26 Patentee after: Shenyang Midea Medical Instrument Co., Ltd. Address before: 110023 No. 47-2 Shen Liaodong Road, Tiexi District, Liaoning, Shenyang Patentee before: Du Nan |
|
| CX01 | Expiry of patent term | ||
| CX01 | Expiry of patent term |
Granted publication date: 20101117 |